Fritextsökning
Innehållstyper
-
Positiva resultat mot Huntingtons sjukdom
Det första läkemedlet inriktat mot orsaken till Huntingtons sjukdom är säkert och vältolererat i den första kliniska prövningen och sänker halterna av huntingtin.
-
Einar Pontén, Managing Director, Merck Sequant
Why are you going to Scanlab+Biotech Forum?
-
Då är det läge att notera biotechbolaget
Life Science Sweden har frågat två branschpersoner vad man ska tänka på innan en börsnotering av ett biotech- eller annat life science-företag.
-
Next generation sequencer in an accessible format
The GS Junior System is a new benchtop-sized next generation sequencing platform.
-
Acadia drug awarded
Acadia Pharmaceutical has got an award for a new treatment against Parkinson's disease.
-
Virusforskare får Scilifelabpris
Forskningsinstitutet delar i samarbete med tidskriften Science ut pris till unga forskare.
-
Parnevik firm in Swiss osteoporosis deal
The golf legend Jesper Parnevik's drug delivery firm EffRx has signed a license agreement with Nycomed for a new drug against osteoporosis.
-
Biovitrum sells UK part
Biovitrum will soon spin-out a British subsidary
-
Respiratorius hunts millions
The biopharmaceutical company Respiratorius has got a new CEO, who starts a public new share issue to catch almost SEK ten million.
-
Prisar politiker och Lundaforskare
Riksdagsledamoten Barbro Westerholm och professorn Catharina Svanborg får pris från Forska Sverige.
-
Danish focus on bio chemicals
The Danish company Genencor and the German company BRAIN establish a research collaboration for the production of biobased chemicals from renewable feedstock.
-
Danish focus on bio chemicals
The Danish company Genencor and the German company BRAIN establish a research collaboration for the production of biobased chemicals from renewable feedstock.
-
Danish focus on bio chemicals
The Danish company Genencor and the German company BRAIN establish a research collaboration for the production of biobased chemicals from renewable feedstock.
-
Danish focus on bio chemicals
The Danish company Genencor and the German company BRAIN establish a research collaboration for the production of biobased chemicals from renewable feedstock.
-
Danish focus on bio chemicals
The Danish company Genencor and the German company BRAIN establish a research collaboration for the production of biobased chemicals from renewable feedstock.
-
Pfizer buys Swiss vaccines
Pfizer executes commercial license agreements for novel human vaccines based on the Swiss company Cytos Biotechnology's Immunodrug technology.
-
Positivt för ny psoriasisbehandling
Kandidat uppvisar uppnådda effektmål och signifikant högre effekt jämfört med biologisk standardbehandling i tre fas III-studier på psoriasis.
-
Recipharm i nytt avtal
Ska tillverka den vaginala tabletten Laccure Vagitorium mot bakteriell vaginos.
-
Forska Sverige förstärker
Tre nya ledamöter går in i stiftelsens styrelse.
-
A1M tar in pengar
Tar in 43,7 miljoner genom emission, planerar byte av börslista och publicerar ny tidsplan för verksamheten.
-
Oss Dsign tankar kassan
Tar in 93 miljoner kronor till sitt marknadsarbete.
-
Many rotor options for refrigerated microcentrifuge
The new 5430 R from Eppendorf is a refrigerated microcentrifuge with several different rotors.
-
KI mörkade kritik
- ledningen påverkade oberoende experters utvärdering.
-
Multiple rotor options in refrigerated microcentrifuge
The new 5430 R from Eppendorf is a refrigerated microcentrifuge with several different rotors.
BREAKING